228 related articles for article (PubMed ID: 29672472)
1. Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant.
Schillie S; Harris A; Link-Gelles R; Romero J; Ward J; Nelson N
MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(15):455-458. PubMed ID: 29672472
[TBL] [Abstract][Full Text] [Related]
2. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management.
Schillie S; Murphy TV; Sawyer M; Ly K; Hughes E; Jiles R; de Perio MA; Reilly M; Byrd K; Ward JW;
MMWR Recomm Rep; 2013 Dec; 62(RR-10):1-19. PubMed ID: 24352112
[TBL] [Abstract][Full Text] [Related]
3. Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant.
Champion CR
Ann Pharmacother; 2021 Jun; 55(6):783-791. PubMed ID: 32988213
[TBL] [Abstract][Full Text] [Related]
4. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.
Schillie S; Vellozzi C; Reingold A; Harris A; Haber P; Ward JW; Nelson NP
MMWR Recomm Rep; 2018 Jan; 67(1):1-31. PubMed ID: 29939980
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults.
Mast EE; Weinbaum CM; Fiore AE; Alter MJ; Bell BP; Finelli L; Rodewald LE; Douglas JM; Janssen RS; Ward JW;
MMWR Recomm Rep; 2006 Dec; 55(RR-16):1-33; quiz CE1-4. PubMed ID: 17159833
[TBL] [Abstract][Full Text] [Related]
6. Association of Number of Doses With Hepatitis B Vaccine Series Completion in US Adults.
Bruxvoort K; Slezak J; Huang R; Ackerson B; Sy LS; Qian L; Reynolds K; Towner W; Solano Z; Mercado C; Hyer R; Janssen R; Jacobsen SJ
JAMA Netw Open; 2020 Nov; 3(11):e2027577. PubMed ID: 33252692
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of human papillomavirus-16/18 AS04-adjuvanted vaccine with hepatitis B vaccine: randomized study in healthy girls.
Schmeink CE; Bekkers RL; Josefsson A; Richardus JH; Berndtsson Blom K; David MP; Dobbelaere K; Descamps D
Vaccine; 2011 Nov; 29(49):9276-83. PubMed ID: 21856349
[TBL] [Abstract][Full Text] [Related]
8. Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.
Girndt M; Houser P; Manllo-Karim R; Ervin JE; Charytan C; Chow S; Symonian-Silver M; Lehrner L; Linfert D; Shemin D; Michelsen A; Xie F; Janssen RS
Vaccine; 2023 May; 41(20):3224-3232. PubMed ID: 37085451
[TBL] [Abstract][Full Text] [Related]
9. Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1709-11. PubMed ID: 22189894
[TBL] [Abstract][Full Text] [Related]
10. The Adult Hepatitis Vaccine Project - California, 2007-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):514-6. PubMed ID: 20448527
[TBL] [Abstract][Full Text] [Related]
11. Considerations for hepatitis B as part of a combination vaccine.
Greenberg DP
Pediatr Infect Dis J; 2001 Nov; 20(11 Suppl):S34-9. PubMed ID: 11704722
[TBL] [Abstract][Full Text] [Related]
12. Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
Weng MK; Doshani M; Khan MA; Frey S; Ault K; Moore KL; Hall EW; Morgan RL; Campos-Outcalt D; Wester C; Nelson NP
MMWR Morb Mortal Wkly Rep; 2022 Apr; 71(13):477-483. PubMed ID: 35358162
[TBL] [Abstract][Full Text] [Related]
13. Update: recommendations to prevent hepatitis B virus transmission--United States.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jan; 48(2):33-4. PubMed ID: 9933127
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents.
Mast EE; Margolis HS; Fiore AE; Brink EW; Goldstein ST; Wang SA; Moyer LA; Bell BP; Alter MJ;
MMWR Recomm Rep; 2005 Dec; 54(RR-16):1-31. PubMed ID: 16371945
[TBL] [Abstract][Full Text] [Related]
15. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
[TBL] [Abstract][Full Text] [Related]
16. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older - United States, 2017.
Kim DK; Riley LE; Harriman KH; Hunter P; Bridges CB
MMWR Morb Mortal Wkly Rep; 2017 Feb; 66(5):136-138. PubMed ID: 28182599
[TBL] [Abstract][Full Text] [Related]
17. HBV-ISS (Dynavax).
Sung JJ; Lik-Yuen H
Curr Opin Mol Ther; 2006 Apr; 8(2):150-5. PubMed ID: 16610768
[TBL] [Abstract][Full Text] [Related]
18. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update.
Lee GH; Lim SG
Expert Rev Vaccines; 2021 May; 20(5):487-495. PubMed ID: 33783302
[No Abstract] [Full Text] [Related]
19. Challenges with hepatitis B vaccination of high risk adults - A pilot program.
Bridges CB; Watson TL; Nelson NP; Chavez-Torres M; Fineis P; Ntiri-Reid B; Wake E; Leahy JM; Kurian AK; Hall MAK; Kennedy ED
Vaccine; 2019 Aug; 37(35):5111-5120. PubMed ID: 31303523
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
